Digital Pathology Leader Adds Third FDA Clearance For Digital Pathology In Breast Can

[News]

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the ER and PR image analysis applications available through its patented ScanScope® slide scanning system.

More... (http://www.medicalnewstoday.com/articles/119626.php)